Saudi Arabia vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)
Saudi Arabia
100.0%
in 2024
Togo
100.0%
in 2024
Saudi Arabia rank
1st
Togo rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Saudi Arabia
- Togo
How they compare
Saudi Arabia currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2008 it was Saudi Arabia ahead.
Saudi Arabia ranks 1st and Togo ranks 1st of 144 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 30.0% | 70.0% | Saudi Arabia |
| 2010s | 99.0% | 95.5% | 3.5% | Saudi Arabia |
| 2020s | 100.0% | 99.2% | 0.8% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Saudi Arabia or Togo?
- Saudi Arabia, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Saudi Arabia and Togo?
- 0.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Togo?
- 10 years are reported by both, from 2008 to 2024.
- How do Saudi Arabia and Togo rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Saudi Arabia ranks 1st and Togo ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.